Cheeseman et al.; “The effect of gastric inhibitory polypeptide and glucagon like peptides on intestinal basolateral membrane hexose transport” The American Physiological Society; Apr. 16, 1996; APSracts 3:0071G. |
Ehrlich et al.; “Inhibition of Pancreatic proglucagon gene expression in mice bearing subcutaneous endocrine Tumors”; American Journal of Physiology; 1994; pp. E662-E671. |
Irwin et al.; “Trout and Chicken Proglucagon: Alternative Splicing Generates mRNA Transcripts Encoding Glucagon-like Peptide 2”; Molecular Endocrinology; vol. 9; 1995; pp. 267-277. |
Mommsen et al.; “Glucagon-like peptides activate hepatic Gluconeogenesis”; FEBS Letters; vol. 219, No. 1; Jul. 1987; pp. 227-232. |
Nishi et al.; “Cloning of Complementary DNAs Encoding Islet Amyloid Polypeptide, Insulin, and Glucagon Precursors from a New World Rodent, the Degu, Octodon degus”; Molecular Endocrinology; 1990; 4:1192-1198. |
Ruiz-Grande et al.; “Renal catabolism of human glucagon-like peptides 1 and 2”; Can. J. Physiology Pharmacology.; vol. 68, No. 12; Dec. 1990; pp. 1568-1573. |
Shennan et al.; “Proglucagon expression, posttranslational processing and secretion in SV40-transformed t Islet cells”; Molecular and Cellular Endocrinology; vol. 67; 1989; pp. 93-99. |
Watanabe et al.; “Trophic Effect of Glucagon-(1-21)-Peptide on the Isolated Rat Ileal Mucosal Cells”; Biochemical and Biophysical Research Communications; vol. 152, No. 3; May 16, 1988; pp. 1038-1044. |
Lund et al.; “Regulation of Intestinal Glucagon Gene Expression During Adaptive Growth of Small Intestine”; Digestion; Nov.-Dec. 1993; pp. 371-373. |
Ørskov et al.; “Pancreatic and Intestinal processing of proglucagon in man”; Diabetologia; vol. 30; 1987; pp. 874-881. |
Ørskov et al.; “Carboxypeptidase-B-like processing of the C-24, terminus of glucagon-like peptide-2 in pig and human small intestine”; FEBS Letters; vol. 247 No. 2; Apr. 1989; pp. 193-196. |
George et al.; Molecular forms of glucagon-like peptides in Man, FEBS Letters; vol. 192, No. 2; 1985; pp. 275-278. |
Hoosein et al.; “Human glucagon-like peptides 1 and 2 activate rat brain adenylate Cyclase”; FEBS Letters; vol. 178, No. 1; Dec. 1984; pp. 83-86. |
Buhl et al.; “Naturally Occurring Products of Proglucagon 111-160 in the Porcine and Human Small Intestine”; The Journal of Biological Chemistry; vol. 263, No. 18; Jun. 25, 1998; pp. 8621-8624. |
Lee et al.; “Glucagon Gene 5′-Flanking Sequences Direct Expression of Simian Virus 40 Large T Antigen to the Intestine, Producing Carcinoma of the Large Bowel in Transgenic Mice”; The Journal of Biological Chemistry; vol. 267, No. 15; May 1992; pp. 10705-10708. |
Ørskov et al.; “Radio-immunoassays for glucagon-like peptides 1 and 2 (GLP-1 and GLP-2)”; Scand. J. Clin. Lab. Invest; vol. 47, No. 2; Apr. 1987; pp. 165-174. |
Barragan et al.; “Changes in arterial blood pressure and heart rate induced by glucagon-like peptide-1-(7-36) amide in rats”; American Journal of Physiology; vol. 266, No. 3, Part 1; Mar. 1994; pp. E459-66. |
Brubaker et al.; “Regulation of Intestinal Proglucagon-Derived Peptide Secretion by Intestinal Regulatory Peptides”; Endocrinology; vol. 128, No. 6; 1991; pp. 3175-3182. |
Calvo et al.; “Structural characterization by affinity cross-linking of Glucagon-like peptide-1(7-36) amide receptor in rat brain”; J. Neurochemistry.; vol. 64, No. 1; Jan. 1995; pp. 299-306. |
Drucker; “Glucagon and the Glucagon-like Peptides”; Pancreas; vol. 5, No. 4; 1990; pp. 484-488. |
Mojsov et al.; “Preproglucagon Gene Expression in Pancreas and Intestine Diversifies at the Level of Post-Translational Processing”; The Journal of Biological Chemistry; vol. 261, No. 25; Sep. 5, 1986; pp. 11880-11889. |
Ørskov et al.; “Glucagon-Like Peptides GLP-1 and GLP-2, Predicted Products of the Glucagon Gene, Are Secreted Separately from Pig Small Intestine but Not Pancreas”; Endocrinology; vol. 119, No. 4; 1986; pp. 1467-1475. |